Cell therapy in Parkinson's disease - stop or go?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 11331920.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The results of the first double-blind placebo-controlled trial using grafts of embryonic tissue to treat Parkinson's disease have aroused widespread interest and debate about the future of cell replacement therapies. What are the key issues that need to be resolved and the directions in which this technology is likely to develop?
Medical subject headings
- Brain Tissue Transplantation
- Parkinson Disease